JNANA THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 04 Aug 2025)
What this means for you
This application is over — abandoned 04 Aug 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90795552
- Mark type
- Design + words
- Filed
- 25 Jun 2021
- Published for opposition
- 08 Nov 2022
- Abandoned
- 04 Aug 2025
- Attorney of record
- Perry J. Viscounty
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations that modulate historically undruggable targets across target classes, namely, solute carrier (SLC) metabolite transporters, transcription factors, signaling scaffolds and phosphatases for the treatment of rare, autoimmune and inflammatory diseases and cancer
Owner
- Jnana Therapeutics Inc., Boston, MA, US
- Jnana Therapeutics Inc., Boston, MA, US
Prosecution history
- 04 Aug 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 04 Aug 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 26 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Nov 2024 — SOU EXTENSION 4 GRANTED
- 25 Nov 2024 — SOU EXTENSION 4 FILED
- 25 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 21 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jun 2024 — SOU EXTENSION 3 GRANTED
- 21 Jun 2024 — SOU EXTENSION 3 FILED
- 21 Jun 2024 — SOU TEAS EXTENSION RECEIVED
- 09 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Dec 2023 — SOU EXTENSION 2 GRANTED
- 07 Dec 2023 — SOU EXTENSION 2 FILED
- 07 Dec 2023 — SOU TEAS EXTENSION RECEIVED
- 21 Jul 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED